Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes
Brain · 03.05.2024 · 147 (5) · 1837-1855
DOI: 10.1093/brain/awad403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 01.12.2023. Verfasst von Berardo Rinaldi und 59 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Receptors, AMPA, Phenotype, Loss of Function Mutation. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, Novo Nordisk Foundation.
Abstract (Originalsprache)
AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors (AMPARs) mediate fast excitatory neurotransmission in the brain. AMPARs form by homo- or heteromeric assembly of subunits encoded by the GRIA1–GRIA4 genes, of which only GRIA3 is X-chromosomal. Increasing numbers of GRIA3 missense variants are reported in patients with neurodevelopmental disorders (NDD), but only a few have been examined functionally. Here, we evaluated the impact on AMPAR function of one frameshift and 43 rare missense GRIA3 variants identified in patients with NDD by electrophysiological assays. Thirty-one variants alter receptor function and show loss-of-function or gain-of-function properties, whereas 13 appeared neutral. We collected detailed clinical data from 25 patients (from 23 families) harbouring 17 of these variants. All patients had global developmental impairment, mostly moderate (9/25) or severe (12/25). Twelve patients had seizures, including focal motor (6/12), unknown onset motor (4/12), focal impaired awareness (1/12), (atypical) absence (2/12), myoclonic (5/12) and generalized tonic-clonic (1/12) or atonic (1/12) seizures. The epilepsy syndrome was classified as developmental and epileptic encephalopathy in eight patients, developmental encephalopathy without seizures in 13 patients, and intellectual disability with epilepsy in four patients. Limb muscular hypotonia was reported in 13/25, and hypertonia in 10/25. Movement disorders were reported in 14/25, with hyperekplexia or non-epileptic erratic myoclonus being the most prevalent feature (8/25). Correlating receptor functional phenotype with clinical features revealed clinical features for GRIA3-associated NDDs and distinct NDD phenotypes for loss-of-function and gain-of-function variants. Gain-of-function variants were associated with more severe outcomes: patients were younger at the time of seizure onset (median age: 1 month), hypertonic and more often had movement disorders, including hyperekplexia. Patients with loss-of-function variants were older at the time of seizure onset (median age: 16 months), hypotonic and had sleeping disturbances. Loss-of-function and gain-of-function variants were disease-causing in both sexes but affected males often carried de novo or hemizygous loss-of-function variants inherited from healthy mothers, whereas affected females had mostly de novo heterozygous gain-of-function variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.
- Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen 2100, Denmark.
- Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Centre, Dianalund 4293, Denmark.
- Department of Regional Health Research, University of Southern Denmark, Odense 5230Denmark.
- State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, Department of Neurology, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210032, China.
- Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 310030, China.
ORCID-Profile: Berardo Rinaldi, Allan Bayat, Jennifer Friedman, Mélanie Fradin
Förderung
- NIA NIH HHS
- NIH HHS
- Novo Nordisk Foundation
- National Natural Science Foundation of China
- National Institutes of Health
- National Key R & D Program of China
- Fundamental Research Funds for the Central Universities
- Special Fund for Science and Technology Innovation Strategy of Guangdong Province
Zitieren
APA
Rinaldi, B., Bayat, A., Zachariassen, L. G., Sun, J. H., Ge, Y. H., Zhao, D., Bonde, K., Madsen, L. H., Awad, I. A. A., Bagiran, D., Sbeih, A., Shah, S. M., El-Sayed, S., Lyngby, S. M., Pedersen, M. G., Stenum-Berg, C., Walker, L. C., Krey, I., Delahaye-Duriez, A., …, & McNiven, V. (2024). Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes. Brain, 147(5), 1837-1855. https://doi.org/10.1093/brain/awad403
Vancouver
Rinaldi B, Bayat A, Zachariassen LG, Sun JH, Ge YH, Zhao D, et al. Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes. Brain. 2024;147(5):1837-1855. doi:10.1093/brain/awad403
BibTeX
@article{Rinaldi2024,
author = {Rinaldi, Berardo and Bayat, Allan and Zachariassen, Linda G and Sun, Jia-Hui and Ge, Yu-Han and Zhao, Dan and Bonde, Kristine and Madsen, Laura H and Awad, Ilham Abdimunim Ali and Bagiran, Duygu and Sbeih, Amal and Shah, Syeda Maidah and El-Sayed, Shaymaa and Lyngby, Signe M and Pedersen, Miriam G and Stenum-Berg, Charlotte and Walker, Louise Claudia and Krey, Ilona and Delahaye-Duriez, Andrée and Emrick, Lisa T and Sully, Krystal and Murali, Chaya N and Burrage, Lindsay C and Plaud Gonzalez, Julie Ana and Parnes, Mered and Friedman, Jennifer and Isidor, Bertrand and Lefranc, Jérémie and Redon, Sylvia and Heron, Delphine and Mignot, Cyril and Keren, Boris and Fradin, Mélanie and Dubourg, Christele and Mercier, Sandra and Besnard, Thomas and Cogne, Benjamin and Deb, Wallid and Rivier, Clotilde and Milani, Donatella and Bedeschi, Maria Francesca and Di Napoli, Claudia and Grilli, Federico and Marchisio, Paola and Koudijs, Suzanna and Veenma, Danielle and Argilli, Emanuela and Lynch, Sally Ann and Au, Ping Yee Billie and Ayala Valenzuela, Fernando Eduardo and Brown, Carolyn and Masser-Frye, Diane and Jones, Marilyn and Patron Romero, Leslie and Li, Wenhui Laura and Thorpe, Erin and Hecher, Laura and Johannsen, Jessika and Denecke, Jonas and McNiven, Vanda},
title = {Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes},
journal = {Brain},
year = {2024},
volume = {147},
number = {5},
pages = {1837--1855},
doi = {10.1093/brain/awad403}
}
EUVIMED